Equinor ASA vs Twist Bioscience Corp — how do they compare? Equinor ASA trades at $40.93 (market cap $97.58B), while Twist Bioscience Corp trades at $125.49 (market cap $7.72B). The key difference: Equinor ASA is far larger — about 12.6× Twist Bioscience Corp's market cap, and Equinor ASA pays a 3.81% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| EQNR | TWST | |
|---|---|---|
Market Cap | $97.58B | $7.72B |
Sector | Energy | Health |
52-Week High | $42.40 | $124.88 |
52-Week Low | $22.41 | $24.16 |
Enterprise Value | $106.28B | $7.65B |
Dividend Yield | 3.81% | — |
Trailing returns across standard periods
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →